相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
Janielle P. Maynard et al.
MOLECULAR CANCER RESEARCH (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome
Nataly Stylianou et al.
ONCOGENE (2019)
Treatment of Advanced Prostate Cancer
Min Yuen Teo et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Shangze Li et al.
CANCER RESEARCH (2019)
Activator of G protein signaling 3 modulates prostate tumor development and progression
Timothy O. Adekoya et al.
CARCINOGENESIS (2019)
TGF--Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Yang Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition
Min A. Seol et al.
SCIENTIFIC REPORTS (2019)
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
Yongning Lu et al.
CELL COMMUNICATION AND SIGNALING (2019)
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER
Jamal Ahel et al.
ACTA CLINICA CROATICA (2019)
Cytokine-mediated communication: a quantitative appraisal of immune complexity
Gregoire Altan-Bonnet et al.
NATURE REVIEWS IMMUNOLOGY (2019)
RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease
Frank Christoph et al.
WORLD JOURNAL OF UROLOGY (2018)
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes
Younghun Jung et al.
CANCER RESEARCH (2018)
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models
Yong Luo et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway
Peng Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression
Yuyang Sun et al.
MOLECULAR CARCINOGENESIS (2018)
Translational models of prostate cancer bone metastasis
Richard B. Berish et al.
NATURE REVIEWS UROLOGY (2018)
Metastatic Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells
Shayna E. Thomas-Jardin et al.
PROSTATE (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
Identification of the tumour transition states occurring during EMT
Ievgenia Pastushenko et al.
NATURE (2018)
Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor
Yutaro Tsubakihara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
TGF-β signaling in cancer metastasis
Feng Xie et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Fractalkine/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1/PI3K/Akt/NF-κB pathway in human osteosarcoma
Ju-Fang Liu et al.
ONCOTARGET (2017)
Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
Sandy Figiel et al.
HUMAN PATHOLOGY (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer
Yidi Guo et al.
MOLECULAR MEDICINE REPORTS (2017)
The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
Mekonnen Sisay et al.
ONCOTARGETS AND THERAPY (2017)
Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth
Ke-Qin Yang et al.
BMC CANCER (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice
Achinto Saha et al.
CANCER RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
Antonella Sistigu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer
Koichiro Takayama et al.
CANCER LETTERS (2017)
The Role of Angiogenesis in Cancer Treatment
Mehdi Rajabi et al.
BIOMEDICINES (2017)
Pre-metastatic niches: organ-specific homes for metastases
Hector Peinado et al.
NATURE REVIEWS CANCER (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells
Jiebing Tang et al.
ONCOLOGY REPORTS (2016)
Transforming growth factor β as regulator of cancer stemness and metastasis
Claudia Bellomo et al.
BRITISH JOURNAL OF CANCER (2016)
Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
Andrew R. Chin et al.
CLINICAL CANCER RESEARCH (2016)
IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway
Hu Qu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Stability of the hybrid epithelial/mesenchymal phenotype
Mohit Kumar Jolly et al.
ONCOTARGET (2016)
CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering
Rajesh Singh et al.
ONCOTARGET (2016)
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim et al.
ONCOTARGET (2016)
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
Justin M. David et al.
VACCINES (2016)
The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer
Elin Richardsen et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer
Aimalie L. Hardaway et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis
Mohammad Imran Khan et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Regulation of vascular endothelial growth factor in prostate cancer
Simone de Brot et al.
ENDOCRINE-RELATED CANCER (2015)
Bone metastasis and the metastatic niche
Guangwen Ren et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells
Xiao-Hui Chen et al.
MOLECULAR IMMUNOLOGY (2015)
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Xin Ye et al.
TRENDS IN CELL BIOLOGY (2015)
STAT3 regulated ARF expression suppresses prostate cancer metastasis
Jan Pencik et al.
NATURE COMMUNICATIONS (2015)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow
Younghun Jung et al.
MOLECULAR CANCER RESEARCH (2015)
Surviving at a Distance: Organ-Specific Metastasis
Anna C. Obenauf et al.
TRENDS IN CANCER (2015)
Mechanisms navigating the TGF-β pathway in prostate cancer
Zheng Cao et al.
ASIAN JOURNAL OF UROLOGY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
Daniel P. Nguyen et al.
BJU INTERNATIONAL (2014)
ALCAM/CD166 Is a TGF-β-Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone
Amanda G. Hansen et al.
CANCER RESEARCH (2014)
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
Gina Chia-Yi Chu et al.
ENDOCRINE-RELATED CANCER (2014)
Regulation of Crosstalk between Epithelial to Mesenchymal Transition Molecules and MMP-9 Mediates the Antimetastatic Activity of Anethole in DU145 Prostate Cancer Cells
ByungChul Ha et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation
Lei Gu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
Elisa Ferretti et al.
MEDIATORS OF INFLAMMATION (2014)
Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer
Makito Miyake et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Prostate Cancer and Bone: The Elective Affinities
Nadia Rucci et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The many faces of neuroendocrine differentiation in prostate cancer progression
Stephane Terry et al.
FRONTIERS IN ONCOLOGY (2014)
CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration
Tien-Huang Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Interleukin-1β Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features
Qingxin Liu et al.
CANCER RESEARCH (2013)
Integrin alpha(2)beta(1) (alpha(2)beta(1)) promotes prostate cancer skeletal metastasis
Joseph L. Sottnik et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases
J.L. Sottnik et al.
CURRENT MOLECULAR MEDICINE (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Stabilization of Snail through AKT/GSK-3 beta signaling pathway is required for TNF-alpha-induced epithelial-mesenchymal transition in prostate cancer PC3 cells
Hao Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6 → Androgen Receptor → TGF-β → MMP-9 Signals
Xiaohai Wang et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro
Sandra Casimiro et al.
PLOS ONE (2013)
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy
Qinwen Wang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Younghun Jung et al.
NATURE COMMUNICATIONS (2013)
Atypical Metastases From Prostate Cancer: 10-Year Experience at a Single Institution
Anant H. Vinjamoori et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Angiogenesis in prostate cancer: onset, progression and imaging
Giovanna Russo et al.
BJU INTERNATIONAL (2012)
The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression
Caroline Schroten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation
Po-Lin Kuo et al.
CARCINOGENESIS (2012)
Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Julius Semenas et al.
CURRENT DRUG TARGETS (2012)
Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model
Zebin Hu et al.
HUMAN GENE THERAPY (2012)
In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line
Lei Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
Chun-Te Wu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma
Viviana P. Montecinos et al.
PLOS ONE (2012)
CXCR4 Expression in Prostate Cancer Progenitor Cells
Anna Dubrovska et al.
PLOS ONE (2012)
Cytokine disbalance in common human cancers
Zoran Culig
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
Rajendra Kumar Singh et al.
CANCER RESEARCH (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line
Qinwen Wang et al.
CELL BIOLOGY INTERNATIONAL (2011)
Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function
C. L. Salanga et al.
EXPERIMENTAL CELL RESEARCH (2011)
Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse
Seung Wook Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Steps in prostate cancer progression that lead to bone metastasis
Jung-Kang Jin et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer
Chantal Mengus et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
Blockade of Transforming Growth Factor-beta (TGFβ) Signaling Inhibits OsteoblasticTumorigenesis by a Novel Human Prostate Cancer Cell Line
Sweta Mishra et al.
PROSTATE (2011)
Pathogenesis of Osteoblastic Bone Metastases From Prostate Cancer
Toni Ibrahim et al.
CANCER (2010)
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
Elisa Giannoni et al.
CANCER RESEARCH (2010)
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
Federica Marchesi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
Frederic R. Santer et al.
ENDOCRINE-RELATED CANCER (2010)
Interleukin-6 in bone metastasis and cancer progression
Tasnim Ara et al.
EUROPEAN JOURNAL OF CANCER (2010)
VEGF and prostatic cancer: a systematic review
Francisco Botelho et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Mechanism of lymph node metastasis in prostate cancer
Kaustubh Datta et al.
FUTURE ONCOLOGY (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
Liat Izhak et al.
JOURNAL OF IMMUNOLOGY (2010)
Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
Jian Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
The Expression of Osteoclastogenesis-Associated Factors and Osteoblast Response to Osteolytic Prostate Cancer Cells
Colm Morrissey et al.
PROSTATE (2010)
VEGF Inhibitors and Prostate Cancer Therapy
Jeanny Aragon-Ching et al.
Current Molecular Pharmacology (2010)
Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
Hong Pu et al.
CANCER RESEARCH (2009)
A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
Xin Li et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Yi Lu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Emerging roles of chemokines in prostate cancer
David Vindrieux et al.
ENDOCRINE-RELATED CANCER (2009)
Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression
Elisabeth Jones et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Prostate Cancer Promotes CD11b Positive Cells to Differentiate Into Osteoclasts
Kosuke Mizutani et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
Mohd W. Nasser et al.
JOURNAL OF IMMUNOLOGY (2009)
The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
Merav Darash-Yahana et al.
PLOS ONE (2009)
Effects of CXCR4 Antagonist CTCE-9908 on Prostate Tumor Growth
Stacy Porvasnik et al.
PROSTATE (2009)
Expression of RANK-ligand in prostate cancer cell lines
Hendrik Penno et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2009)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown A possible metastasis preventing and minimizing approach
Yifei Xing et al.
CANCER BIOLOGY & THERAPY (2008)
New insights into the role of CXCR4 in prostate cancer metastasis
Candece L. Gladson et al.
CANCER BIOLOGY & THERAPY (2008)
CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: Potential role in prostate cancer bone tropism
Whitney L. Jamieson et al.
CANCER RESEARCH (2008)
CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
Jianhua Wang et al.
CANCER RESEARCH (2008)
Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer
Takuya Akashi et al.
CANCER SCIENCE (2008)
CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells
Weidong Hu et al.
CANCER SCIENCE (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
Valerie A. Odero-Marah et al.
CELL RESEARCH (2008)
Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
Haiyen E. Zhau et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro
Yi Lu et al.
MOLECULAR CANCER RESEARCH (2008)
RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
Robert E. Miller et al.
MOLECULAR CANCER THERAPEUTICS (2008)
被撤回的出版物: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (Retracted article. See vol. 298, 2022)
Jianhua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor, metastasis genes
Allison P. Armstrong et al.
PROSTATE (2008)
Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability
Melissa L. Petreaca et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells
P. J. Maxwell et al.
ONCOGENE (2007)
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
Robert D. Loberg et al.
CANCER RESEARCH (2007)
PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro
Yi Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases
Colm Morrissey et al.
BMC CANCER (2007)
Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer
Shinako Araki et al.
CANCER RESEARCH (2007)
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
N. Cabioglu et al.
ANNALS OF ONCOLOGY (2007)
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption
Yi Lu et al.
CANCER RESEARCH (2007)
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo et al.
NATURE (2007)
DU145 human prostate cancer cells express functional receptor activator of NFκB:: New insights in the prostate cancer bone metastasis process
K. Mori et al.
BONE (2007)
Cytokines, Inflammation, and Pain
Jun-Ming Zhang et al.
INTERNATIONAL ANESTHESIOLOGY CLINICS (2007)
Biology of RANK, RANKL, and osteoprotegerin
Brendan F. Boyce et al.
ARTHRITIS RESEARCH & THERAPY (2007)
The evolving biology and treatment of prostate cancer
Russel S. Taichman et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Interleukin 6 is associated with cachexia in patients with prostate cancer
Kenji Kuroda et al.
UROLOGY (2007)
被撤回的出版物: A glycolytic mechanism regulating an angiogenic switch in prostate cancer (Retracted article. See vol. 81, pg. 1623, 2021)
Jianhua Wang et al.
CANCER RESEARCH (2007)
Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome
Melanie M. L. Green et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Expression and activation of alpha(V)beta(3) integrins by SDF-I/CXCI2 increases the aggressiveness of prostate cancer cells
Yan-Xi Sun et al.
PROSTATE (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
The metastatic cascade in prostate cancer
Manit Arya et al.
SURGICAL ONCOLOGY-OXFORD (2006)
Type I collagen receptor (α2β1) signaling promotes the growth of human prostate cancer cells within the bone
Christopher L. Hall et al.
CANCER RESEARCH (2006)
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
Yi Lu et al.
PROSTATE (2006)
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
Gaoping Chen et al.
CANCER (2006)
CCL2 is a potent regulator of prostate cancer cell migration and proliferation
Robert D. Loberg et al.
NEOPLASIA (2006)
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer
Gaetano Leto et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
CXCR4 chemokine receptor mediates prostate tumor cell adhesion through α5 and β3 Integrins
Tobias Engl et al.
NEOPLASIA (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12
SR Chinni et al.
PROSTATE (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity
Y Kitagawa et al.
CANCER RESEARCH (2005)
Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis
SY Wong et al.
CANCER RESEARCH (2005)
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis
K Jennbacken et al.
PROSTATE (2005)
Blockade of transforming growth factor-β signaling suppresses progression of androgen-independent human prostate cancer in nude mice
FH Zhang et al.
CLINICAL CANCER RESEARCH (2005)
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer
C Murphy et al.
CLINICAL CANCER RESEARCH (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Crosstalk between cancer cells and bone microenvironment in bone metastasis
T Yoneda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480
DJ George et al.
CLINICAL CANCER RESEARCH (2005)
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation
PM Ghosh et al.
ENDOCRINE-RELATED CANCER (2005)
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
YX Sun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Osteoblasts in prostate cancer metastasis to bone
CJ Logothetis et al.
NATURE REVIEWS CANCER (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
LS Steelman et al.
LEUKEMIA (2004)
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein
JL Dai et al.
CANCER RESEARCH (2004)
Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells
R Aalinkeel et al.
CANCER RESEARCH (2004)
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis
H Mochizuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells
SA Shulby et al.
CANCER RESEARCH (2004)
CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion
S Singh et al.
LABORATORY INVESTIGATION (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Angiogenesis and prostate cancer tumor growth
B Nicholson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer
V Michalaki et al.
BRITISH JOURNAL OF CANCER (2004)
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
M Darash-Yahana et al.
FASEB JOURNAL (2004)
Serum interleukin-8 is elevated in men with prostate cancer and bone metastases
S Lehrer et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2004)
Molecular pathway for cancer metastasis to bone
S De et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genetic regulation of osteoclast development and function
SL Teitelbaum et al.
NATURE REVIEWS GENETICS (2003)
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo
YX Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
The loss of TGF-β signaling promotes prostate cancer metastasis
WH Tu et al.
NEOPLASIA (2003)
The role of angiogenesis in prostate development and the pathogenesis of prostate cancer
D Hrouda et al.
UROLOGICAL RESEARCH (2003)
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone
Y Lee et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2003)
Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma
SH Lang et al.
PROSTATE (2002)
Cytokine and cytokine receptor pleiotropy and redundancy
K Ozaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
SF Shariat et al.
UROLOGY (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
J Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Osteoprotegerin and rank ligand expression in prostate cancer
JM Brown et al.
UROLOGY (2001)
Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer
MA Dall'Era et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2001)
Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice
SJ Kim et al.
NEOPLASIA (2001)
Cytokine receptor signaling pathways
WJ Leonard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Differences in the expression and effects of interleukin-1 and -2 on androgen-sensitive and -insensitive human prostate cancer cell lines
M Abdul et al.
CANCER LETTERS (2000)
分享论文
